WALPAR NUTRITIONS LTD previously known as Walpar healthcare whose journey initiated with direct selling business model which deals scientifically proved products selling directly to common people with nutritional specific diseases. From that time only they got nurtured with concentration of customer satisfaction and quality conscious products development, trusting on the experiences they had gained as a brand.
They raised a network of possessions, time-honored a set of core values, and cultivated a team that was second to none. These efforts earned us the esteem and trustworthiness of their clients as well as recognition by Pharmatech Magazine, The CIMS Business Awards as “Fastest Growing Nutraceutical Company”, and Best in Biz among others – hardening our domicile as a nutraceutical industry pioneer and supposed groundbreaker.
Mr. Kalpesh Pravinchandra Ladhawala, Mr. Tanmay Kumar Ashwinbhai and Mrs. Sejal Kalpesh Ladhawala are the company promoters.
Particulars | 31-Mar-20 | 31-Mar-19 | 31-Mar-18 |
---|---|---|---|
Total Assets (In ₹ Millions) | 1,317.41 | 918.09 | 390.37 |
Total Revenue (In ₹ Millions) | 1,671.27 | 1,282.27 | 644.53 |
Profit After Tax (PAT) (In ₹ Millions) | 12.18 | 6.88 | 0.33 |
Date & Time | QIB | NII | RII | Total |
---|---|---|---|---|
Day 1 - 30 Jun 2021 | ||||
Day 2 - 1 Jul 2021 | ||||
Day 3 - 2 Jul 2021 | ||||
Day 4 - 05 Jul 2021 |
Please click the link below to check the IPO allotment status.
IPO Allotment StatusWalpar Nutritions Limited IPO will open on 30 Jun 2021 and close on 05 Jul 2021.
Walpar Nutritions Limited IPO will list on 13 Jul 2021.
The offer price of Walpar Nutritions Limited IPO is ₹55.
The lot size of Walpar Nutritions Limited IPO is 2000.
The Grey Market Premium (GMP) price of Walpar Nutritions Limited IPO is Not Available at the moment.
The Kostak price of Walpar Nutritions Limited IPO is Not Available at the moment.
The Subject to Sauda price for Walpar Nutritions Limited IPO is Not Available at the moment.
Please Leave Your Message
Walpar Nutritions Limited IPO Review/Comments